1 Study Coverage 1.1 Thymalfasin for Injection Product Introduction 1.2 Market by Type 1.2.1 Global Thymalfasin for Injection Market Size Growth Rate by Type 1.2.2 1.6 mg Type 1.2.3 Others 1.3 Market by Application 1.3.1 Global Thymalfasin for Injection Market Size Growth Rate by Application 1.3.2 Chronic Hepatitis B 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Thymalfasin for Injection Market Size, Estimates and Forecasts 2.1.1 Global Thymalfasin for Injection Revenue 2016-2027 2.1.2 Global Thymalfasin for Injection Sales 2016-2027 2.2 Global Thymalfasin for Injection, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Thymalfasin for Injection Historical Market Size by Region (2016-2021) 2.3.1 Global Thymalfasin for Injection Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Thymalfasin for Injection Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Thymalfasin for Injection Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Thymalfasin for Injection Sales Forecast by Region (2022-2027) 2.4.2 Global Thymalfasin for Injection Revenue Forecast by Region (2022-2027) 3 Global Thymalfasin for Injection Competitor Landscape by Players 3.1 Global Top Thymalfasin for Injection Manufacturers by Sales 3.1.1 Global Thymalfasin for Injection Sales by Manufacturer (2016-2021) 3.1.2 Global Thymalfasin for Injection Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Thymalfasin for Injection Manufacturers by Revenue 3.2.1 Key Thymalfasin for Injection Manufacturers Covered: Ranking by Revenue 3.2.2 Global Thymalfasin for Injection Revenue by Manufacturers (2016-2021) 3.2.3 Global Thymalfasin for Injection Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Thymalfasin for Injection Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Thymalfasin for Injection Revenue in 2020 3.2.6 Global Thymalfasin for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Thymalfasin for Injection Price by Manufacturers 3.4 Global Thymalfasin for Injection Manufacturing Base Distribution, Product Types 3.4.1 Thymalfasin for Injection Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Thymalfasin for Injection Product Type 3.4.3 Date of International Manufacturers Enter into Thymalfasin for Injection Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Thymalfasin for Injection Market Size by Type (2016-2021) 4.1.1 Global Thymalfasin for Injection Sales by Type (2016-2021) 4.1.2 Global Thymalfasin for Injection Revenue by Type (2016-2021) 4.1.3 Thymalfasin for Injection Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Thymalfasin for Injection Market Size Forecast by Type (2022-2027) 4.2.1 Global Thymalfasin for Injection Sales Forecast by Type (2022-2027) 4.2.2 Global Thymalfasin for Injection Revenue Forecast by Type (2022-2027) 4.2.3 Thymalfasin for Injection Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Thymalfasin for Injection Market Size by Application (2016-2021) 5.1.1 Global Thymalfasin for Injection Sales by Application (2016-2021) 5.1.2 Global Thymalfasin for Injection Revenue by Application (2016-2021) 5.1.3 Thymalfasin for Injection Price by Application (2016-2021) 5.2 Thymalfasin for Injection Market Size Forecast by Application (2022-2027) 5.2.1 Global Thymalfasin for Injection Sales Forecast by Application (2022-2027) 5.2.2 Global Thymalfasin for Injection Revenue Forecast by Application (2022-2027) 5.2.3 Global Thymalfasin for Injection Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Thymalfasin for Injection Market Size YoY Growth 2016-2027 6.1.1 Japan Thymalfasin for Injection Sales YoY Growth 2016-2027 6.1.2 Japan Thymalfasin for Injection Revenue YoY Growth 2016-2027 6.1.3 Japan Thymalfasin for Injection Market Share in Global Market 2016-2027 6.2 Japan Thymalfasin for Injection Market Size by Players (International and Local Players) 6.2.1 Japan Top Thymalfasin for Injection Players by Sales (2016-2021) 6.2.2 Japan Top Thymalfasin for Injection Players by Revenue (2016-2021) 6.3 Japan Thymalfasin for Injection Historic Market Review by Type (2016-2021) 6.3.1 Japan Thymalfasin for Injection Sales Market Share by Type (2016-2021) 6.3.2 Japan Thymalfasin for Injection Revenue Market Share by Type (2016-2021) 6.3.3 Japan Thymalfasin for Injection Price by Type (2016-2021) 6.4 Japan Thymalfasin for Injection Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Thymalfasin for Injection Sales Forecast by Type (2022-2027) 6.4.2 Japan Thymalfasin for Injection Revenue Forecast by Type (2022-2027) 6.4.3 Japan Thymalfasin for Injection Price Forecast by Type (2022-2027) 6.5 Japan Thymalfasin for Injection Historic Market Review by Application (2016-2021) 6.5.1 Japan Thymalfasin for Injection Sales Market Share by Application (2016-2021) 6.5.2 Japan Thymalfasin for Injection Revenue Market Share by Application (2016-2021) 6.5.3 Japan Thymalfasin for Injection Price by Application (2016-2021) 6.6 Japan Thymalfasin for Injection Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Thymalfasin for Injection Sales Forecast by Application (2022-2027) 6.6.2 Japan Thymalfasin for Injection Revenue Forecast by Application (2022-2027) 6.6.3 Japan Thymalfasin for Injection Price Forecast by Application (2022-2027) 7 North America 7.1 North America Thymalfasin for Injection Market Size YoY Growth 2016-2027 7.2 North America Thymalfasin for Injection Market Facts & Figures by Country 7.2.1 North America Thymalfasin for Injection Sales by Country (2016-2021) 7.2.2 North America Thymalfasin for Injection Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Thymalfasin for Injection Market Size YoY Growth 2016-2027 8.2 Asia Pacific Thymalfasin for Injection Market Facts & Figures by Region 8.2.1 Asia Pacific Thymalfasin for Injection Sales by Region (2016-2021) 8.2.2 Asia Pacific Thymalfasin for Injection Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Thymalfasin for Injection Market Size YoY Growth 2016-2027 9.2 Europe Thymalfasin for Injection Market Facts & Figures by Country 9.2.1 Europe Thymalfasin for Injection Sales by Country (2016-2021) 9.2.2 Europe Thymalfasin for Injection Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Thymalfasin for Injection Market Size YoY Growth 2016-2027 10.2 Latin America Thymalfasin for Injection Market Facts & Figures by Country 10.2.1 Latin America Thymalfasin for Injection Sales by Country (2016-2021) 10.2.2 Latin America Thymalfasin for Injection Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Thymalfasin for Injection Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Thymalfasin for Injection Market Facts & Figures by Country 11.2.1 Middle East and Africa Thymalfasin for Injection Sales by Country (2016-2021) 11.2.2 Middle East and Africa Thymalfasin for Injection Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 SciClone Pharmaceuticals 12.1.1 SciClone Pharmaceuticals Corporation Information 12.1.2 SciClone Pharmaceuticals Description and Business Overview 12.1.3 SciClone Pharmaceuticals Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.1.4 SciClone Pharmaceuticals Thymalfasin for Injection Products Offered 12.1.5 SciClone Pharmaceuticals Recent Development 12.2 Shanghai No.1 Biochemical&Pharmaceutical 12.2.1 Shanghai No.1 Biochemical&Pharmaceutical Corporation Information 12.2.2 Shanghai No.1 Biochemical&Pharmaceutical Description and Business Overview 12.2.3 Shanghai No.1 Biochemical&Pharmaceutical Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Shanghai No.1 Biochemical&Pharmaceutical Thymalfasin for Injection Products Offered 12.2.5 Shanghai No.1 Biochemical&Pharmaceutical Recent Development 12.3 Haiyue Pharmaceutical 12.3.1 Haiyue Pharmaceutical Corporation Information 12.3.2 Haiyue Pharmaceutical Description and Business Overview 12.3.3 Haiyue Pharmaceutical Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Haiyue Pharmaceutical Thymalfasin for Injection Products Offered 12.3.5 Haiyue Pharmaceutical Recent Development 12.4 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical 12.4.1 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Corporation Information 12.4.2 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Description and Business Overview 12.4.3 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Thymalfasin for Injection Products Offered 12.4.5 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Recent Development 12.5 Hunan Sailong Biological Pharmaceutical 12.5.1 Hunan Sailong Biological Pharmaceutical Corporation Information 12.5.2 Hunan Sailong Biological Pharmaceutical Description and Business Overview 12.5.3 Hunan Sailong Biological Pharmaceutical Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Hunan Sailong Biological Pharmaceutical Thymalfasin for Injection Products Offered 12.5.5 Hunan Sailong Biological Pharmaceutical Recent Development 12.6 Hybio 12.6.1 Hybio Corporation Information 12.6.2 Hybio Description and Business Overview 12.6.3 Hybio Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Hybio Thymalfasin for Injection Products Offered 12.6.5 Hybio Recent Development 12.7 Sinopep 12.7.1 Sinopep Corporation Information 12.7.2 Sinopep Description and Business Overview 12.7.3 Sinopep Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Sinopep Thymalfasin for Injection Products Offered 12.7.5 Sinopep Recent Development 12.8 Langtian 12.8.1 Langtian Corporation Information 12.8.2 Langtian Description and Business Overview 12.8.3 Langtian Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Langtian Thymalfasin for Injection Products Offered 12.8.5 Langtian Recent Development 12.9 Hairui Pharmaceuticals 12.9.1 Hairui Pharmaceuticals Corporation Information 12.9.2 Hairui Pharmaceuticals Description and Business Overview 12.9.3 Hairui Pharmaceuticals Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Hairui Pharmaceuticals Thymalfasin for Injection Products Offered 12.9.5 Hairui Pharmaceuticals Recent Development 12.10 Shengnuo Biotechnology 12.10.1 Shengnuo Biotechnology Corporation Information 12.10.2 Shengnuo Biotechnology Description and Business Overview 12.10.3 Shengnuo Biotechnology Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Shengnuo Biotechnology Thymalfasin for Injection Products Offered 12.10.5 Shengnuo Biotechnology Recent Development 12.11 SciClone Pharmaceuticals 12.11.1 SciClone Pharmaceuticals Corporation Information 12.11.2 SciClone Pharmaceuticals Description and Business Overview 12.11.3 SciClone Pharmaceuticals Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.11.4 SciClone Pharmaceuticals Thymalfasin for Injection Products Offered 12.11.5 SciClone Pharmaceuticals Recent Development 12.12 CR DOUBLE-CRANE 12.12.1 CR DOUBLE-CRANE Corporation Information 12.12.2 CR DOUBLE-CRANE Description and Business Overview 12.12.3 CR DOUBLE-CRANE Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.12.4 CR DOUBLE-CRANE Products Offered 12.12.5 CR DOUBLE-CRANE Recent Development 12.13 DIAO Group 12.13.1 DIAO Group Corporation Information 12.13.2 DIAO Group Description and Business Overview 12.13.3 DIAO Group Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.13.4 DIAO Group Products Offered 12.13.5 DIAO Group Recent Development 12.14 Shuangcheng Pharma 12.14.1 Shuangcheng Pharma Corporation Information 12.14.2 Shuangcheng Pharma Description and Business Overview 12.14.3 Shuangcheng Pharma Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Shuangcheng Pharma Products Offered 12.14.5 Shuangcheng Pharma Recent Development 12.15 Hainan Zhonghe Pharmaceutical 12.15.1 Hainan Zhonghe Pharmaceutical Corporation Information 12.15.2 Hainan Zhonghe Pharmaceutical Description and Business Overview 12.15.3 Hainan Zhonghe Pharmaceutical Thymalfasin for Injection Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Hainan Zhonghe Pharmaceutical Products Offered 12.15.5 Hainan Zhonghe Pharmaceutical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Thymalfasin for Injection Industry Trends 13.2 Thymalfasin for Injection Market Drivers 13.3 Thymalfasin for Injection Market Challenges 13.4 Thymalfasin for Injection Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Thymalfasin for Injection Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Thymalfasin for Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of 1.6 mg Type Table 3. Major Manufacturers of Others Table 4. Global Thymalfasin for Injection Market Size Growth Rate by Application (2021-2027) & (K Units) Table 5. Global Thymalfasin for Injection Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Thymalfasin for Injection Sales by Regions (2016-2021) & (K Units) Table 7. Global Thymalfasin for Injection Sales Market Share by Regions (2016-2021) Table 8. Global Thymalfasin for Injection Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Thymalfasin for Injection Sales Forecast by Region (2022-2027) & (K Units) Table 10. Global Thymalfasin for Injection Sales Market Share Forecast by Region (2022-2027) Table 11. Global Thymalfasin for Injection Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Thymalfasin for Injection Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Thymalfasin for Injection Sales by Manufacturers (2016-2021) (K Units) Table 14. Global Thymalfasin for Injection Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Thymalfasin for Injection Manufacturers by Revenue (US$ Million) in 2020 Table 16. Thymalfasin for Injection Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Thymalfasin for Injection Revenue Share by Manufacturers (2016-2021) Table 18. Global Thymalfasin for Injection Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Thymalfasin for Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thymalfasin for Injection as of 2020) Table 20. Key Manufacturers Thymalfasin for Injection Price (2016-2021) (US$/Unit) Table 21. Thymalfasin for Injection Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Thymalfasin for Injection Product Type Table 23. Date of International Manufacturers Enter into Thymalfasin for Injection Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Thymalfasin for Injection Sales by Type (2016-2021) (K Units) Table 26. Global Thymalfasin for Injection Sales Share by Type (2016-2021) Table 27. Global Thymalfasin for Injection Revenue by Type (2016-2021) (US$ Million) Table 28. Global Thymalfasin for Injection Revenue Share by Type (2016-2021) Table 29. Thymalfasin for Injection Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 30. Global Thymalfasin for Injection Sales Forecast by Type (2022-2027) & (K Units) Table 31. Global Thymalfasin for Injection Sales Market Share Forecast by Type (2022-2027) Table 32. Global Thymalfasin for Injection Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Thymalfasin for Injection Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Thymalfasin for Injection Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 35. Global Thymalfasin for Injection Sales by Application (2016-2021) (K Units) Table 36. Global Thymalfasin for Injection Sales Share by Application (2016-2021) Table 37. Global Thymalfasin for Injection Revenue by Application (2016-2021) (US$ Million) Table 38. Global Thymalfasin for Injection Revenue Share by Application (2016-2021) Table 39. Thymalfasin for Injection Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 40. Global Thymalfasin for Injection Sales Forecast by Application (2022-2027) & (K Units) Table 41. Global Thymalfasin for Injection Sales Market Share Forecast by Application (2022-2027) Table 42. Global Thymalfasin for Injection Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Thymalfasin for Injection Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Thymalfasin for Injection Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 45. Japan Thymalfasin for Injection Sales (K Units) of Key Companies (2016-2021) Table 46. Japan Thymalfasin for Injection Sales Share by Company (2016-2021) Table 47. Japan Thymalfasin for Injection Revenue (US$ Million) by Company (2016-2021) Table 48. Japan Thymalfasin for Injection Revenue Share by Company (2016-2021) Table 49. Japan Thymalfasin for Injection Sales (K Units) by Type (2016-2021) Table 50. Japan Thymalfasin for Injection Sales Share by Type (2016-2021) Table 51. Japan Thymalfasin for Injection Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. Japan Thymalfasin for Injection Price (US$/Unit) by Type (2016-2021) Table 53. Japan Thymalfasin for Injection Sales (K Units) by Type (2022-2027) Table 54. Japan Thymalfasin for Injection Sales Share by Type (2022-2027) Table 55. Japan Thymalfasin for Injection Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. Japan Thymalfasin for Injection Revenue Share by Type (2022-2027) Table 57. Japan Thymalfasin for Injection Price (US$/Unit) by Type (2022-2027) Table 58. Japan Thymalfasin for Injection Sales (K Units) by Application (2016-2021) Table 59. Japan Thymalfasin for Injection Sales Share by Application (2016-2021) Table 60. Japan Thymalfasin for Injection Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. Japan Thymalfasin for Injection Price (US$/Unit) by Application (2016-2021) Table 62. Japan Thymalfasin for Injection Sales (K Units) by Application (2022-2027) Table 63. Japan Thymalfasin for Injection Sales Share by Application (2022-2027) Table 64. Japan Thymalfasin for Injection Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. Japan Thymalfasin for Injection Revenue Share by Application (2022-2027) Table 66. Japan Thymalfasin for Injection Price (US$/Unit) by Application (2022-2027) Table 67. North America Thymalfasin for Injection Sales by Country (2016-2021) & (K Units) Table 68. North America Thymalfasin for Injection Sales Market Share by Country (2016-2021) Table 69. North America Thymalfasin for Injection Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Thymalfasin for Injection Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Thymalfasin for Injection Sales by Region (2016-2021) & (K Units) Table 72. Asia Pacific Thymalfasin for Injection Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Thymalfasin for Injection Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Thymalfasin for Injection Revenue Market Share by Region (2016-2021) Table 75. Europe Thymalfasin for Injection Sales by Country (2016-2021) & (K Units) Table 76. Europe Thymalfasin for Injection Sales Market Share by Country (2016-2021) Table 77. Europe Thymalfasin for Injection Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Thymalfasin for Injection Revenue Market Share by Country (2016-2021) Table 79. Latin America Thymalfasin for Injection Sales by Country (2016-2021) & (K Units) Table 80. Latin America Thymalfasin for Injection Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Thymalfasin for Injection Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Thymalfasin for Injection Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Thymalfasin for Injection Sales by Country (2016-2021) & (K Units) Table 84. Middle East and Africa Thymalfasin for Injection Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Thymalfasin for Injection Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Thymalfasin for Injection Revenue Market Share by Country (2016-2021) Table 87. SciClone Pharmaceuticals Corporation Information Table 88. SciClone Pharmaceuticals Description and Business Overview Table 89. SciClone Pharmaceuticals Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 90. SciClone Pharmaceuticals Thymalfasin for Injection Product Table 91. SciClone Pharmaceuticals Recent Development Table 92. Shanghai No.1 Biochemical&Pharmaceutical Corporation Information Table 93. Shanghai No.1 Biochemical&Pharmaceutical Description and Business Overview Table 94. Shanghai No.1 Biochemical&Pharmaceutical Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 95. Shanghai No.1 Biochemical&Pharmaceutical Product Table 96. Shanghai No.1 Biochemical&Pharmaceutical Recent Development Table 97. Haiyue Pharmaceutical Corporation Information Table 98. Haiyue Pharmaceutical Description and Business Overview Table 99. Haiyue Pharmaceutical Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 100. Haiyue Pharmaceutical Product Table 101. Haiyue Pharmaceutical Recent Development Table 102. Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Corporation Information Table 103. Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Description and Business Overview Table 104. Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 105. Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Product Table 106. Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Recent Development Table 107. Hunan Sailong Biological Pharmaceutical Corporation Information Table 108. Hunan Sailong Biological Pharmaceutical Description and Business Overview Table 109. Hunan Sailong Biological Pharmaceutical Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 110. Hunan Sailong Biological Pharmaceutical Product Table 111. Hunan Sailong Biological Pharmaceutical Recent Development Table 112. Hybio Corporation Information Table 113. Hybio Description and Business Overview Table 114. Hybio Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 115. Hybio Product Table 116. Hybio Recent Development Table 117. Sinopep Corporation Information Table 118. Sinopep Description and Business Overview Table 119. Sinopep Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 120. Sinopep Product Table 121. Sinopep Recent Development Table 122. Langtian Corporation Information Table 123. Langtian Description and Business Overview Table 124. Langtian Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 125. Langtian Product Table 126. Langtian Recent Development Table 127. Hairui Pharmaceuticals Corporation Information Table 128. Hairui Pharmaceuticals Description and Business Overview Table 129. Hairui Pharmaceuticals Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 130. Hairui Pharmaceuticals Product Table 131. Hairui Pharmaceuticals Recent Development Table 132. Shengnuo Biotechnology Corporation Information Table 133. Shengnuo Biotechnology Description and Business Overview Table 134. Shengnuo Biotechnology Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 135. Shengnuo Biotechnology Product Table 136. Shengnuo Biotechnology Recent Development Table 137. HPGC Corporation Information Table 138. HPGC Description and Business Overview Table 139. HPGC Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 140. HPGC Product Table 141. HPGC Recent Development Table 142. CR DOUBLE-CRANE Corporation Information Table 143. CR DOUBLE-CRANE Description and Business Overview Table 144. CR DOUBLE-CRANE Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 145. CR DOUBLE-CRANE Product Table 146. CR DOUBLE-CRANE Recent Development Table 147. DIAO Group Corporation Information Table 148. DIAO Group Description and Business Overview Table 149. DIAO Group Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 150. DIAO Group Product Table 151. DIAO Group Recent Development Table 152. Shuangcheng Pharma Corporation Information Table 153. Shuangcheng Pharma Description and Business Overview Table 154. Shuangcheng Pharma Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 155. Shuangcheng Pharma Product Table 156. Shuangcheng Pharma Recent Development Table 157. Hainan Zhonghe Pharmaceutical Corporation Information Table 158. Hainan Zhonghe Pharmaceutical Description and Business Overview Table 159. Hainan Zhonghe Pharmaceutical Thymalfasin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 160. Hainan Zhonghe Pharmaceutical Product Table 161. Hainan Zhonghe Pharmaceutical Recent Development Table 162. Thymalfasin for Injection Market Trends Table 163. Thymalfasin for Injection Market Drivers Table 164. Thymalfasin for Injection Market Challenges Table 165. Thymalfasin for Injection Market Restraints Table 166. Thymalfasin for Injection Customers List Table 167. Thymalfasin for Injection Distributors List Table 168. Research Programs/Design for This Report Table 169. Key Data Information from Secondary Sources Table 170. Key Data Information from Primary Sources List of Figures Figure 1. Thymalfasin for Injection Product Picture Figure 2. Global Thymalfasin for Injection Sales Market Share by Type in 2020 & 2027 Figure 3. 1.6 mg Type Product Picture Figure 4. Others Product Picture Figure 5. Global Thymalfasin for Injection Sales Market Share by Application in 2020 & 2027 Figure 6. Chronic Hepatitis B Figure 7. Others Figure 8. Thymalfasin for Injection Report Years Considered Figure 9. Global Thymalfasin for Injection Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Thymalfasin for Injection Market Size 2016-2027 (US$ Million) Figure 11. Global Thymalfasin for Injection Sales 2016-2027 (K Units) Figure 12. Global Thymalfasin for Injection Market Size Market Share by Region: 2021 Versus 2027 Figure 13. Global Thymalfasin for Injection Sales Market Share by Region (2016-2021) Figure 14. Global Thymalfasin for Injection Sales Market Share by Region in 2020 Figure 15. Global Thymalfasin for Injection Revenue Market Share by Region (2016-2021) Figure 16. Global Thymalfasin for Injection Revenue Market Share by Region in 2020 Figure 17. Global Thymalfasin for Injection Sales Share by Manufacturer in 2020 Figure 18. The Top 10 and 5 Players Market Share by Thymalfasin for Injection Revenue in 2020 Figure 19. Thymalfasin for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 20. Global Thymalfasin for Injection Sales Market Share by Type (2016-2021) Figure 21. Global Thymalfasin for Injection Sales Market Share by Type in 2020 Figure 22. Global Thymalfasin for Injection Revenue Market Share by Type (2016-2021) Figure 23. Global Thymalfasin for Injection Revenue Market Share by Type in 2020 Figure 24. Global Thymalfasin for Injection Sales Market Share by Application (2016-2021) Figure 25. Global Thymalfasin for Injection Sales Market Share by Application in 2020 Figure 26. Global Thymalfasin for Injection Revenue Market Share by Application (2016-2021) Figure 27. Global Thymalfasin for Injection Revenue Market Share by Application in 2020 Figure 28. Japan Thymalfasin for Injection Sales Growth Rate 2016-2027 (K Units) Figure 29. Japan Thymalfasin for Injection Revenue Growth Rate 2016-2027 (US$ Million) Figure 30. Japan Thymalfasin for Injection Market Share in Global Market 2016-2027 Figure 31. Japan 5 and 10 Largest Thymalfasin for Injection Players Market Share by Revenue in Thymalfasin for Injection in 2020 Figure 32. Japan Thymalfasin for Injection Revenue Share by Type (2016-2021) Figure 33. Japan Thymalfasin for Injection Revenue Growth Rate by Type in 2016 & 2020 Figure 34. Japan Thymalfasin for Injection Revenue Share by Application (2016-2021) Figure 35. Japan Thymalfasin for Injection Revenue Growth Rate by Application in 2016 & 2020 Figure 36. North America Thymalfasin for Injection Sales Growth Rate 2016-2021 (K Units) Figure 37. North America Thymalfasin for Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 38. North America Thymalfasin for Injection Sales Market Share by Country in 2020 Figure 39. North America Thymalfasin for Injection Revenue Market Share by Country in 2020 Figure 40. U.S. Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 41. U.S. Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Canada Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 43. Canada Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Europe Thymalfasin for Injection Sales Growth Rate 2016-2021 (K Units) Figure 45. Europe Thymalfasin for Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 46. Europe Thymalfasin for Injection Sales Market Share by Country in 2020 Figure 47. Europe Thymalfasin for Injection Revenue Market Share by Country in 2020 Figure 48. Germany Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 49. Germany Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. France Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 51. France Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. U.K. Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 53. U.K. Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. Italy Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 55. Italy Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Russia Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 57. Russia Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Asia Pacific Thymalfasin for Injection Sales Growth Rate 2016-2021 (K Units) Figure 59. Asia Pacific Thymalfasin for Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 60. Asia Pacific Thymalfasin for Injection Sales Market Share by Region in 2020 Figure 61. Asia Pacific Thymalfasin for Injection Revenue Market Share by Region in 2020 Figure 62. China Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 63. China Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 64. Japan Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 65. Japan Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. South Korea Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 67. South Korea Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. India Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 69. India Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. Australia Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 71. Australia Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Taiwan Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 73. Taiwan Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Indonesia Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 75. Indonesia Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Thailand Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 77. Thailand Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Malaysia Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 79. Malaysia Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Philippines Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 81. Philippines Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Vietnam Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 83. Vietnam Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Latin America Thymalfasin for Injection Sales Growth Rate 2016-2021 (K Units) Figure 85. Latin America Thymalfasin for Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 86. Latin America Thymalfasin for Injection Sales Market Share by Country in 2020 Figure 87. Latin America Thymalfasin for Injection Revenue Market Share by Country in 2020 Figure 88. Mexico Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 89. Mexico Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 90. Brazil Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 91. Brazil Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Argentina Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 93. Argentina Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Middle East and Africa Thymalfasin for Injection Sales Growth Rate 2016-2021 (K Units) Figure 95. Middle East and Africa Thymalfasin for Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 96. Middle East and Africa Thymalfasin for Injection Sales Market Share by Country in 2020 Figure 97. Middle East and Africa Thymalfasin for Injection Revenue Market Share by Country in 2020 Figure 98. Turkey Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 99. Turkey Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 100. Saudi Arabia Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 101. Saudi Arabia Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. UAE Thymalfasin for Injection Sales Growth Rate (2016-2021) (K Units) Figure 103. UAE Thymalfasin for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. Thymalfasin for Injection Value Chain Figure 105. Channels of Distribution Figure 106. Distributors Profiles Figure 107. Bottom-up and Top-down Approaches for This Report Figure 108. Data Triangulation Figure 109. Key Executives Interviewed

SciClone Pharmaceuticals Shanghai No.1 Biochemical&Pharmaceutical Haiyue Pharmaceutical Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Hunan Sailong Biological Pharmaceutical Hybio Sinopep Langtian Hairui Pharmaceuticals Shengnuo Biotechnology HPGC CR DOUBLE-CRANE DIAO Group Shuangcheng Pharma Hainan Zhonghe Pharmaceutical